ARTICLE
Auteur(s) : Maria
Vittoria Masala1, Carla Olivieri2, Cesare
Pirodda1, Maria Antonietta Montesu1, Maria
Antonietta Cuccuru1, Sara Pruneddu1, Cesare
Danesino1, Decio Cerimele1
1Department of Dermatology, University of Sassari,
Viale S Pietro N° 43, 09100 Sassari, Italy
2Department of Human and Hereditary Pathology. Section
of General Biology and Medical Genetics, University of Pavia.
Pavia
accepté le 10 Janvier 2007
Werner syndrome (WS, MIM#277700) is a very rare autosomal recessive
disorder. The Werner gene (WRN, MIM#604611) was cloned in 1996 on
the short arm of chromosome 8 (8p12): it encodes a homolog of the
E. coli Rec Q DNA helicase (RECQL2). The gene functionally
interacts with a DNA polymerase, required for DNA replication and
DNA repair, and therefore is related to the maintenance of DNA
integrity.WS clinical signs include altered distribution of
subcutaneous fat, juvenile bilateral cataracts, a mask-like face
and bird-like nose, trophic ulcers of the feet, diabetes mellitus,
and premature atherosclerosis. The habitus is characteristic, with
short stature, stocky trunk and slender extremities [1]. About
1,270 cases were described worldwide up until 2002: approximately
80% of them were of Japanese ancestry and 70% were born of
consanguineous marriages. WS frequency has been roughly estimated
to be 1: 100,000 in Japan and 1: 1,000,000-1: 10,000,000 outside of
Japan [2]. The only exception to the latter data can be seen in the
clustering of WS in Sardinia [3, 4]. Indeed, the minimum prevalence
of WS in North Sardinia has recently been estimated to be 1: 59,000
[4].13 patients affected by W.S. have been reported in North
Sardinia over the last 25 years comprising: 7 members of one large
family group, in 1979 [3]; three more cases, 1 sporadic case and
two sisters, all belonging to different families, in 1982 [5]; 2
siblings, in 1994 [6]; finally, in 2003, 1 sporadic case [7]. Since
2003, 5 new cases have been observed: 4 members of the same large
family group and 1 sporadic case. Therefore, the total number of
cases described in North Sardinia amounts to 18 with 15 familial
(11 members being of the same family group) and 3 sporadic.A short
clinical description of the 5 new cases is reported.
Case reports
Patient 1
V. P., a 38-year-old female, came to our observation in March 2001
complaining of progressive scleroderma-like skin changes which had
started 25 years before. This was associated with bilateral
cataracts, and pains in her feet and legs while standing or walking
which had started 8 years previously (figure 1), family A, case
III).
Family history revealed that her parents were first cousins and
her brother had died of Cooley’s anaemia.
On physical examination, we observed: low stature, spread and
exaggerated wrinkles in the face and the neck (figure 2), and thin grey
hair. Her feet were slender, subcutaneous fat had disappeared, and
hyperkeratotic calluses were present. The bony vault was
exaggerated because of subcutaneous fat disappearance (figure 3). The voice was
high-pitched.
X-rays revealed widespread osteoporosis, and lamellar calcinosis
of the heel tuberositas. Laboratory investigation revealed
hypercholesterolemia, mild increase in hepatic enzymes (sGOT 57
U/L, sGPT 63). Endocrinology evaluation revealed precocious
menopause.
Patient 2
In June 2002 M. G., female (figure 1), family A, case
IV) and V.P.’s first cousin came under our observation. Family
history showed that her parents were consanguineous, she was the
third affected in a family of nine siblings; indeed, she was a
sister of the two patients described in 1979 (3).
M.G.’s past history revealed that menarche had occurred at the
age of 13. She was affected by Cooley’s anaemia and so subject to
frequent blood transfusions. In addition, she had developed a
serious heart failure and diabetes. Bilateral cataracts had
developed in the third decade. Physical examination showed small
stature (128 cm), and thin grey hair. The voice was hoarse.
All extremities showed marked atrophy of the subcutaneous tissue
and muscle. Patient presented bilateral trophic ulcers at the
perimalleolar and heel regions. The patient died, aged 36, of
cachexia.
Patient 3
V. M., a 32-year-old female, born of consanguineous parents (figure 1), family A,
case I) and cousin on the maternal side of patient n°1.
She came under our observation in May 2003 complaining that from
the age of 18 she had suffered from loss of hair and precocious
greying and fine wrinkles in the periocular areas. In that same
period she had observed the spontaneous loss of some molars and
tapering in the feet due to progressive loss of subcutaneous fat.
At 29 years of age, visual disturbances had developed and a
diagnosis of bilateral posterior cataract had been made;
polyarthralgia and ostealgia had also appeared. At the age of 30,
the patient had become pregnant and was delivered of a normal child
after a normal pregnancy. At the age of 31, arthralgia and
ostealgia had worsened with the appearance of calcinosis on the
soles of the feet.
Our physical examination revealed high pitched voice, low
stature (145 cm tall), peribuccal and periocular wrinkles, and
thin grey hair. The extremities were very slender with a serious
loss of subcutaneous fat. The patient presented flat feet, and
muscle wasting in the legs.
Laboratory findings were normal, X-ray tests revealed widespread
osteoporosis, and soft tissue calcification.
Patient 4
V.A.D., aged 25, female (figure 1), family A, case
II) and V.M.’s younger sister. She came to our department in June
2003, after her sister’s diagnosis of WS. She was 137 cm tall
and her clinical history revealed that her growth had ceased at the
age of 12 (figure
4). Menarche had occurred at the age of 13. She referred
recent widespread arthralgias in the foot, knee and lumbar regions.
At clinical observation she showed: short stature, bird-like
facies, reduction of subcutaneous tissues in the legs which
appeared thin, and plantar hyperkeratosis. Slight opacity of the
lenses was observed, but no cataract had yet developed. Laboratory
findings were normal.
Patient 5
We observed M.D., aged 33, male (figure 1), family B, case
V) in 2004. His parents were related: M.D.’s mother was her
mother-in-law’s second cousin. Past history revealed that growth
had stopped at 15, at 165 cm, and at the same age the first
grey hairs had appeared. Since childhood the patient had had
problems with his sight. During the second decade bilateral
cataracts developed and were extracted at the age of 30.
At physical examination we noted: characteristic bird-like
facies, slender extremities, and a prominent abdomen. The skin was
taut and slightly hyperpigmented, fine wrinkles were present in the
periocular and peribuccal regions and the hair was completely grey,
with sparse pubic and axillary hair. In addition, we observed
slight atrophy of the testes. Laboratory findings showed
hypercholesterolemia, and an increase in hepatic enzymes (sGOT 61
U/I, sGPT67 U/I).
Follow-up on the surviving patients is still underway at
three-monthly intervals.
In all patients the clinical diagnosis was made on the basis of
major and minor criteria proposed by the International Registry of
Werner syndrome group [2], and was confirmed by genetic analyses.
After informed consent, we obtained peripheral blood from all
patients, with exception of patient n°4, for cytogenetic and
genomic molecular analyses.
Chromosomes were studied with standard procedures and at least
20 metaphases for each subject were analysed. Chromosomal
aberrations found by cytogenetic analysis in affected subjects were
as expected for WS [8].
In the molecular analyses, the DNA was amplified by PCR using
primers used for exons 18 and 19 and primers designed by C.O. for
IVS 18. With this test we were able to characterise the disease
causing mutation at genomic DNA level in all five cases,
identifying a homozygous g. nt 77177 a>g mutation (Genbank acc#
AY442327) [9].
Discussion
The WRN protein is a multifunctional nuclear protein that catalyzes
three DNA-dependent reactions: a 3’-5’ helicase, a 3’-5’
exonuclease and an ATPase. In vitro WRN binds and is catalytically
active toward non-canonical DNA structures such as recombination
intermediates, replication forks, repair intermediates and
telomeric ends. Deficiency in WRN results in a cellular phenotype
of genomic instability [10]. More than 40 different mutations were
detected up until 2004, including deletions, nucleotide additions,
point mutations inactivating splice acceptor sites of some of the
exons and point mutations in the coding sequence of the gene [2].
The clinical features of patients affected by WS are strikingly
similar in spite of the fact that different mutations may be at
work in different patients. The common final alteration of the
genetic defect and the pleiotropic effects of WRN could go some way
to explaining this conundrum. A further point of interest is that
despite the numerous mutations found, phenotypical aspects remain
the same worldwide.
Most of mutations result in a truncated WRN protein that lacks
the C-terminal and the nuclear localization signal (WLS). A splice
mutation occurring at one base upstream of nucleotide 3370 in exon
26 was the most frequent mutation found in Japan, accounting for
61% of total WRN mutations: mutation at nucleotide 1336 in exon 9
accounted for 21% and mutation at nucleotide 4144 in exon 33
accounted for 9% [11]. Thus, the inability of WRN to be transported
into the nucleus would seem to be critical for the pathogenesis of
WS.
In our four patients, the genetic molecular studies showed a
homozygous g. nt 77177 a> g mutation (Genbank acc AY442327).
This mutation inserts a new 5’ splice site (↑ At/Gt). At 3’ cryptic
splice site (↓ag) is present 106 bp upstream and explains the 106
bp insertion [9]. This mutation had been seen in another family
member A by Yu et al. [12], who had found a cDNA 105 bp insertion
between exons 18 and 19 of WRN gene, but effected no further
characterizations. The presence of this homozygous mutation in two
unrelated families would suggest a founder effect. Microsatellite
analysis in order to verify this hypothesis is currently in
progress.
The description of five new WS cases in North Sardinia confirms
the high prevalence of the disease reported in our previous papers
[3, 5]. Four of these new patients are offspring of the family
grouping reported in 1982; the subjects affected at that time were
seven, so the total number of patients in this family now amounts
to eleven.
The large number of WS patients in Sardinia may have at least
two explanations. First, the poor connections between Sardinia and
the Italian mainland which, until 50 years ago, amounted to one
daily boat service. In addition, even internal communications on
the island itself were hampered, due to the scarcity of road and
railway networks. Second, the frequency of consanguineous marriage,
partly due to this geographic isolation and partly to avoid the
excessive fragmentation of small land and sheep holdings which were
the main property assets and nutritional sources for country
families.
The appearance of four new cases in the large family group
previously described (family A) during the last five years has
induced us to start a program of genetic counselling in
collaboration with the Department of Medical Genetics of the
University of Pavia. In addition, a proposal to Health Service
authorities is underway for the implementation of an educational
campaign aimed at heightening awareness among the population, so as
to prevent the emergence of new WS cases.
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Herd RM, Faragher RGA, Shall S, Hunter JAA.
Werner’s syndrome: a review of the clinical and pathological
features and pathogenesis. Eur J Dermatol 1993; 3: 425-32.
2 Goto M. Clinical Aspects of Werner’s Syndrome: Its
Natural History and the Genetics of the Disease. In: Lebel M,
ed. “Molecular Mechanisms of Werner’s Syndrome”. New York: Kluver
Academic Plenum Publishers, 2004: 1-11.
3 Rabbiosi G, Borroni G. Werner’s sindrome: seven
cases in one family. Dermatologica 1979; 158: 355-60.
4 Piras D, Masala MV, Cerimele D. Werner’s
sindrome in Northern Sardinia. Epidemiology and clinical update. G
Ital Dermat Vener 2004; 139: 67-74.
5 Cerimele D, Cottoni F, Scappaticci S,
Rabbiosi G, Borroni G, Sanna E, Zei G,
Fraccaro M. High prevalence of Werner’s Sindrome in Sardinia.
Description of Six Patients and Estimate of the Gene Frequency. Hum
Genet 1982; 62: 25-30.
6 Cottoni F, Scappaticci S, Faedda R,
Capra E, Murgia A. Werner’s sindrome associated with
myelofibrosis. J Amer Acad Dermat 1994; 30: 1034-6.
7 Piras D, Cottoni F, Cerimele D. Prevalence of
Werner’s sindrome in northern Sardinia: a new case. J Eur Acad
Dermatol Venereol 2003; 17: 248-9.
8 Scappatticci S, Forabosco A, Borroni G,
Orecchia G, Fraccaro M. Clonal structural chromosomal
rearrangementes in lymphocytes of our patients with Werner’s
syndrome. Ann Genet 1990; 33: 5-8.
9 Masala M, Olivieri C, Pirodda C,
Cottoni F, Danesino C, Cerimele D. Werner Sindrome:
Identification of the Homzygous g.nt 77177 a g Mutation (Genbank
acc#AY442327) in the WRN Gene in Two Apparently Unrelated Italian
Families for Sardinia Suggests a Founder Effect. J Invest Dermat
2005; 125(3 supp.); (A24 P138).
10 Von Kobbe C, Thoma NH, Czyzewski BK,
Pavletich NP, Bohr VA. Werner Syndrome Protein Contains
Three Structure-specific DNA binding Domains. J Biol Chem 2003;
278: 52997-3006.
11 Sogabe Y, Yasuda M, Yokoyama Y, Tamura A,
Negishi I, Ohnishi K, Shinozaki T, Ishikawa O.
Genetic analyses of two cases of Werner’s syndrome. Eur J Dermatol
2004; 14(6): 379-82.
12 Yu CE, Oshima J, Wijsman EM, Nakura J,
Miki T, Piussan C, Matthews S, Fu YH,
Mulligan J, Martin GM, Schellenberg GD. Mutations in
the consensus helicase domains of the Werner syndrome gene.
Werner’s Syndrome Collaborative Group. Am J Hum Genet 1997; 60(2):
330-41.
|